Jump to Header Jump to Main Content Jump to Footer
Featured News Glioblastoma patient's tumor no longer measurable thanks to promising clinical trial

Bota said the trial is designed for patients to enroll for a year, and then decide for how long they would like to continue on with the infusions. Stopping treatment runs the risk of recurrence, which is something Johnson and her parents are acutely aware of.